Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.05B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$404M |
| 3 |
AstraZeneca
AZN
|
+$342M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$288M |
| 5 |
Willis Towers Watson
WTW
|
+$227M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Icahn Enterprises
IEP
|
+$641M |
| 2 |
Microsoft
MSFT
|
+$549M |
| 3 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$538M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$294M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.22% |
| 2 | Financials | 7.52% |
| 3 | Healthcare | 6.46% |
| 4 | Consumer Discretionary | 6.41% |
| 5 | Communication Services | 4.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FRWAU
3176
DELISTED
PWP Forward Acquisition Corp. I Units
FRWAU
| $995K | ﹤0.01% |
100,000
| – | – |
|
|
AUS
3177
DELISTED
Austerlitz Acquisition Corporation I
AUS
| $992K | ﹤0.01% |
+100,000
| New | +$992K |
|
3178
Columbia Diversified Fixed Income Allocation ETF
DIAL
$387M
| $991K | ﹤0.01% |
46,000
| – | – |
|
|
NXDR
3179
Nextdoor Holdings
NXDR
$847M
| $991K | ﹤0.01% |
100,000
-391,425
| -80% | -$3.96M |
|
3180
ProShares UltraPro QQQ
TQQQ
$32.1B
| $990K | ﹤0.01% |
32,316
| – | – |
|
3181
Sinclair Inc
SBGI
$992M
| $987K | ﹤0.01% |
29,698
+12,741
| +75% | +$412K |
|
|
BXMX
3182
DELISTED
Nuveen S&P 500 Buy-Write Income Fund
BXMX
| $986K | ﹤0.01% |
68,594
-9,505
| -12% | -$134K |
|
3183
Invesco China Technology ETF
CQQQ
$3.03B
| $985K | ﹤0.01% |
11,704
+1,503
| +15% | +$122K |
|
3184
Health Catalyst
HCAT
$154M
| $983K | ﹤0.01% |
17,702
+13,715
| +344% | +$731K |
|
3185
John Wiley & Sons Class A
WLY
$2.65B
| $983K | ﹤0.01% |
16,337
-37,901
| -70% | -$2.25M |
|
3186
Preferred Bank
PFBC
$1.24B
| $982K | ﹤0.01% |
15,515
+5,528
| +55% | +$368K |
|
|
AVNS
3187
DELISTED
Avanos Medical
AVNS
| $981K | ﹤0.01% |
26,994
+22,352
| +482% | +$924K |
|
3188
ORIX
IX
$44B
| $979K | ﹤0.01% |
57,830
+6,205
| +12% | +$106K |
|
3189
iShares JPMorgan EM Local Currency Bond ETF
LEMB
$741M
| $979K | ﹤0.01% |
22,422
-11,113
| -33% | -$486K |
|
3190
OSI Systems
OSIS
$3.65B
| $978K | ﹤0.01% |
9,629
+1,075
| +13% | +$105K |
|
3191
JFrog
FROG
$9.66B
| $977K | ﹤0.01% |
21,466
+20,128
| +1,504% | +$906K |
|
3192
Invesco S&P International Developed Low Volatility ETF
IDLV
$345M
| $975K | ﹤0.01% |
31,536
-2,414
| -7% | -$74.9K |
|
3193
Performance Food Group
PFGC
$18B
| $975K | ﹤0.01% |
20,097
-2,743
| -12% | -$145K |
|
3194
Cohu
COHU
$2.26B
| $974K | ﹤0.01% |
26,476
+6,357
| +32% | +$252K |
|
|
TBCH
3195
Turtle Beach Corp
TBCH
$243M
| $972K | ﹤0.01% |
30,457
-20,666
| -40% | -$626K |
|
|
HTLF
3196
DELISTED
Heartland Financial USA, Inc.
HTLF
| $971K | ﹤0.01% |
20,665
-8,288
| -29% | -$413K |
|
|
ISEE
3197
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $971K | ﹤0.01% |
153,848
-45,375
| -23% | -$293K |
|
3198
Cue Biopharma
CUE
$113M
| $968K | ﹤0.01% |
2,771
+296
| +12% | +$115K |
|
|
DNB
3199
DELISTED
Dun & Bradstreet
DNB
| $968K | ﹤0.01% |
45,278
+10,272
| +29% | +$230K |
|
3200
AMERISAFE
AMSF
$543M
| $967K | ﹤0.01% |
16,197
+8,398
| +108% | +$533K |
|
Similar funds
Citigroup's Q2 2021 Portfolio in Review
As of Q2 2021, Citigroup held 6,654 positions worth $166B, up 7.5% from $155B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Citigroup's Q2 2021 filing shows 397 new, 2,681 increased, 2,205 reduced and 444 closed positions. Its largest new stake was Elliott Opportunity II Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant: 7,128,000 shares worth $71.4M. The largest sale was Icahn Enterprises, an estimated $641M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.
- Citigroup's largest Q2 2021 buy was Elliott Opportunity II Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant: 7,128,000 shares worth $71.4M.
- Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $2.05B increase.
- Citigroup's biggest Q2 2021 reduction was Icahn Enterprises, cutting an estimated $641M.
- Citigroup fully exited RealPage, Inc. in Q2 2021, selling an estimated $226M.
- Citigroup's ten largest holdings make up 20% of its $166B portfolio in Q2 2021.
- Citigroup opened 397 new positions and closed 444 in Q2 2021.
- Citigroup's portfolio value rose 7.5% quarter-over-quarter to $166B.
Based on Citigroup's 13F filing for Q2 2021, filed 10 Aug 2021.